Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex

Int J Mol Sci. 2024 Nov 25;25(23):12644. doi: 10.3390/ijms252312644.

Abstract

NMDA receptors in the prefrontal cortex (PFC) play a crucial role in cognitive functions. Previous research has indicated that angiotensin II (Ang II) affects learning and memory. This study aimed to examine how Ang II impacts NMDA receptor activity in layer V pyramidal cells of the rat PFC. Whole-cell patch-clamp experiments were performed in pyramidal cells in brain slices of 9-12-day-old rats. NMDA (30 μM) induced inward currents. Ang II (0.001-1 µM) significantly enhanced NMDA currents in about 40% of pyramidal cells. This enhancement was reversed by the AT1 antagonist eprosartan (1 µM), but not by the AT2 receptor antagonist PD 123319 (5 μM). When pyramidal neurons were synaptically isolated, the increase in NMDA currents due to Ang II was eliminated. Additionally, the dopamine D1 receptor antagonist SCH 23390 (10 μM) reversed the Ang II-induced enhancement, whereas the D2 receptor antagonist sulpiride (20 μM) had no effect. The potentiation of NMDA currents in a subpopulation of layer V pyramidal neurons by Ang II, involving AT1 receptor activation and dopaminergic signaling, may serve as an underlying mechanism for the effects of the renin-angiotensin system (RAS) elements on neuronal functions.

Keywords: AT1 angiotensin receptor; D1 dopamine receptor; NMDA receptor; RAS; neuromodulation; prefrontal cortex.

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Benzazepines
  • Imidazoles / pharmacology
  • Male
  • N-Methylaspartate / metabolism
  • N-Methylaspartate / pharmacology
  • Patch-Clamp Techniques
  • Prefrontal Cortex* / cytology
  • Prefrontal Cortex* / drug effects
  • Prefrontal Cortex* / metabolism
  • Pyramidal Cells* / drug effects
  • Pyramidal Cells* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1* / metabolism
  • Receptors, Dopamine D1 / antagonists & inhibitors
  • Receptors, Dopamine D1 / metabolism
  • Receptors, N-Methyl-D-Aspartate* / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate* / metabolism

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Angiotensin II Type 1 Receptor Blockers
  • N-Methylaspartate
  • Imidazoles
  • Receptors, Dopamine D1
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • SCH 23390
  • Benzazepines